0

Global Immune Thrombocytopenia Drugs Market 2019-2023

  • Published: May 2019
  • Pages: 136
  • SKU: IRTNTR31389
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Industry Insights

The global immune thrombocytopenia drugs market size will grow by USD 919.81 million during 2019-2023 at a CAGR of almost 5%. The high prevalence of associated risk factors for immune thrombocytopenia and the development of biosimilars are some of the factors expected to drive market growth. This market report provides a detailed analysis of the market by product (TPO-RAs, corticosteroids, IVIGs, and other drugs) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including Amgen Inc., CSL Ltd., Horizon Therapeutics Plc, Merck & Co. Inc., Novartis AG, and Rigel Pharmaceuticals Inc.

Key Insights from Immune Thrombocytopenia Drugs Market – Global Forecast 2019-2023

Immune Thrombocytopenia Drugs Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the immune thrombocytopenia drugs market report.

Request a FREE sample now!

End-users prefer biosimilars over biologics because of their low cost. The low cost of biosimilars can be attributed to the fewer number of clinical trials required for approval. The upcoming expiration of patents in the immune thrombocytopenia drugs market will fuel the development of biosimilars for those products. For instance, the forthcoming expiration of patents of Nplate (romiplostim) and rituximab has encouraged market vendors to develop their biosimilars. This will also create several opportunities for new vendors to enter the market. Hence, the growing popularity and development of biosimilars will augment the growth of the immune thrombocytopenia drugs market throughout the next five years.

Young women and people who have rheumatoid arthritis, lupus, and antiphospholipid syndrome are highly susceptible to immune thrombocytopenia. Immune thrombocytopenia may be caused by human immunodeficiency virus (HIV) and hepatitis infections in adults while the disease may occur after a viral illness such as mumps or flu in children. The high prevalence of such diseases and infections across the world will increase the chances of immune thrombocytopenia. As a result, the demand for treatment options and drugs to cure immune thrombocytopenia will also grow. The high prevalence of associated risk factors for immune thrombocytopenia will be one of the significant factors responsible for the growth of the market at a CAGR of almost 5% during the forecast period.

Industry Analysis

Quantitative Data

  • Market size for 2018
  • Market forecast for 2019 to 2023
  • Regional market opportunities
  • Market segment opportunities
  • Growth momentum: Overall market and individual market segments
  • Market condition: 2018
  • Market segmentation based on product: TPO-RAs, corticosteroids, IVIGs, and other drugs
  • Market size, market forecast, and growth momentum
  • Market size and forecast in Asia, Europe, North America, and ROW
  • Market forecasts for key countries

 

Qualitative Data

  • Porter’s Five Forces analysis
  • Trends, drivers, and challenges
  • Vendor landscape
  • Market structure
  • Criticality of inputs
  • Factors of differentiation
  • Market landscape disruption
  • Market maturity
  • Disruption threats
  • Factors driving disruptions
  • Competitive landscape
  • Vendor classification
  • Market positioning of vendors
  • Customer landscape
  • Market fragmentation
  • Sources of disruption

Product Insights

The product segment has been segregated into TPO-RAs, corticosteroids, IVIGs, and other drugs. The TPO-RAs segment accounted for the highest immune thrombocytopenia drugs market share in 2018. During the forecast period, this segment will grow at a faster pace than the overall market. The corticosteroids and IVIGs segments will grow at a slower pace than the overall market.

The increasing demand for approved drugs over off-label corticosteroids will be one of the significant factors fueling immune thrombocytopenia drugs market growth in this segment.

Regional Insights

North America accounted for the highest market share in 2018. The market’s growth in this region will be faster than the growth of the market in other regions and will account for the largest immune thrombocytopenia drugs market share throughout the forecast period. The US is a key market for immune thrombocytopenia drugs in North America.

High prevalence of associated risk factors and the increasing sale of approved drugs for the treatment of immune thrombocytopenia in North America will contribute to the growth of the immune thrombocytopenia drugs market in this region.

Top Immune Thrombocytopenia Drugs Companies

The global immune thrombocytopenia (ITP) drugs market is fragmented. To help clients improve their position, this immune thrombocytopenia drugs market analysis report provides information on the competitive landscape and the products offered by various companies. Moreover, this immune thrombocytopenia drugs market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.

The report offers a detailed analysis of several leading immune thrombocytopenia drugs manufacturers, including:

  • Amgen Inc.
  • CSL Ltd.
  • Horizon Therapeutics Plc
  • Merck & Co., Inc.
  • Novartis AG
  • Rigel Pharmaceuticals Inc.

Segments Covered in the Report

Immune thrombocytopenia drugs market by product

  • Thrombopoietin receptor agonists (TPO-RAs)
  • Corticosteroids
  • Intravenous immunoglobins (IVIGs)
  • Other drugs

Immune thrombocytopenia drugs market by region

  • Asia
  • Europe
  • North America
  • ROW

Key Highlights of the Immune Thrombocytopenia Drugs Market Forecast Report for the Period 2019-2023 

  • CAGR of the market during the forecast period 2019-2023 
  • Detailed information on factors that will accelerate the growth of the immune thrombocytopenia drugs market size during the next five years 
  • Precise estimation of the global ITP drugs market size and its contribution to the parent market 
  • Accurate predictions on upcoming trends and changes in consumer behavior 
  • The growth of the immune thrombocytopenia drugs industry across Asia, Europe, North America, and ROW 
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors 
  • Comprehensive details of factors that will challenge the growth of immune thrombocytopenia drugs companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • TPO-RAs - Market size and forecast 2018-2023
  • Corticosteroids - Market size and forecast 2018-2023
  • IVIGs - Market size and forecast 2018-2023
  • Other drugs - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Special regulatory designations
  • Increasing number of awareness programs
  • Development of biosimilars

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Amgen Inc.
  • CSL Ltd.
  • Horizon Therapeutics Plc
  • Merck & Co., Inc.
  • Novartis AG
  • Rigel Pharmaceuticals Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>